Left ofloxacin and Pidotimod compound preparation
A technology of levofloxacin and pidotimod, applied in pharmaceutical formulas, medical preparations containing active ingredients, antibacterial drugs, etc., can solve the problem of low anti-infection immunity, unrealistic finding of antibiotics, increased cycle time and cost, etc. problem, to achieve the effect of promoting non-specific immune response, excellent safety, and easy to carry and use
Inactive Publication Date: 2005-01-12
SUNSTONE TANGSHAN PHARM CO LTD
View PDF0 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, in recent years, as the problem of antibiotic resistance has become more and more serious, clinicians still face many problems such as complex, refractory infections and recurrent infections in the process of treating bacterial infectious diseases
At the same time, due to the increasing cycle and cost of developing new antibiotics, it is not realistic to find newer and stronger antibiotics in the short term.
The progress of immunological research shows that such patients generally have the problem of low level of anti-infection immunity, and relying solely on exogenous antibacterial drugs is not enough to completely eliminate pathogenic bacteria, and it is easy to leave hidden dangers of drug resistance. Combination strategies to treat infections, especially the use of appropriate immunotherapeutic drugs, should be the best way to treat bacterial infections by improving the patient's own anti-infection immunity and mobilizing the body's endogenous anti-infection ability
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0019] Embodiment sees the following table:
[0020] Table 1 Example
[0021]
[0022] The beneficial effect of the present invention is further illustrated below by the curative effect report.
[0023] Compound preparation of levofloxacin and pidotimod in the treatment of chronic
[0024] Clinical curative effect report on acute exacerbation of bronchitis
[0025] [Objective] To observe the clinical curative effect of compound preparation of levofloxacin and pidotimod on acute exacerbation of chronic bronchitis
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
A compound medicine for exogenously killing pathogenic bacteria and endogenously improving immunity to treat bacterium-infections diseases is prepared from levoofloxacin and Piduomode.
Description
technical field [0001] The invention relates to a compound preparation of levofloxacin and pidotimod, which is used for treating bacterial infectious diseases. Background technique [0002] Infectious diseases are common problems encountered in clinical work, and about 80% of the infections in adults are caused by bacteria, involving outpatients and inpatients in various clinical departments. The most important clinical method for bacterial infection is the use of various antibiotics, making antibiotic products an important product in the field of pharmaceutical production. However, in recent years, as the problem of antibiotic resistance has become more and more serious, clinicians still face many problems such as complex, refractory infections and recurrent infections in the process of treating bacterial infectious diseases. At the same time, due to the increasing cycle and cost of developing new antibiotics, it is not realistic to find newer and stronger antibiotics in t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/5383A61K38/05A61P31/04
Inventor 韩志强贾晓冬
Owner SUNSTONE TANGSHAN PHARM CO LTD
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
